By Pushkala Aripaka and Maggie Fick (Reuters) -AstraZeneca shares rose on Thursday after the drugmaker said it could face a ...

DeepSeek-related shares surged in mainland China after weeklong public holidays. But broader markets were weighed by Trump's ...

SHANGHAI (Reuters) - Chinese companies, from chip makers to cloud service providers, are rushing to support DeepSeek's artificial intelligence models, spurring analysts to hail a "watershed moment" ...

Wang Yun’an, the 38-year-old founder of Guming Holdings, is on the cusp of becoming a billionaire as his company prepares for an initial public offering in Hong Kong.

Asian equities rebounded, and tariff talk became more bark than bite for Canada and Mexico as the U.S. dollar fell.

Shares of Merck are sliding in early trading after the drugmaker surprised Wall Street with a lower-than-expected 2025 sales ...

Merck said it will pause shipments of Gardasil to China through at least mid-year, as continued weak demand for the HPV vaccine there is expected to hurt 2025 revenue, but it still posted a strong ...

China’s machine-learning sector has experienced considerable growth, and is predicted to grow by an average of 34.8% a year ...

Merck posted Q4 sales of $15.62 billion, driven by Keytruda's 19% growth. FY25 guidance lags estimates, citing Gardasil ...

Merck’s full-year 2025 revenue guidance fell short of what some analysts were expecting, at a range of $64.1 billion to $65.6 ...